Clinical Papers & Posters.
NETosis and Nucleosome Biomarkers in Septic Shock & Critical COVID-19 Patients
ISTH 2022: Evaluation and comparison of NETosis biomarkers in sepsis and COVID-19 patients
High specificity lung cancer test to rule out cancer in non-malignant lung nodules found at LDCT.
Circulating nucleosomes to identify non-smoker subjects at risk of lung cancer and triage them for low-dose CT scan.
Circulating nucleosomes predict response to tyrosine kinase inhibitors in hepatocellular carcinoma
Nu.Q® Capture-MS allows the epigenetic profile analysis of circulating nucleosomes in non-Hodgkin lymphoma patients
Circulating nucleosomes levels improve FIT performance for detecting high-risk colorectal neoplasms in a symptomatic population.
Circulating nucleosomes for Detection of Colorectal Cancer and High risk Advanced Adenomas
Identifying tools to track hypercoagulability in COVID-19 patients: Exploring global haemostasis (ROTEM) and neutrophil extracellular traps (NETs) immunoassays
Circulating Nucleosome Immunoassay: Evaluating a Clinically-Applicable Test to Risk Stratify COVID-19 and Target Anticoagulation
Serial profiling of cell‑free DNA and nucleosome histone modifications in cell cultures
A Novel Proteomics Approach to Epigenetic Profiling of Circulating Nucleosomes
Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression
Therapeutic Removal of NETs from Blood in a Pig Model of Sepsis
Circulating nucleosomes in hematological malignancy ASCO 2020
Performance of a Nu.Q H3.1 assay for lung cancer detection ASCO 2020
Enrichment of circulating tumor DNA from cell-free DNA of hematopoietic origin ASCO 2020
Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve